Surface Oncology Inc (SURF)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-08-11 | 2023-08-01 | S Sale |
Chief Executive Officer Officer |
16,713
-16.7%
0.94USD 15,710 |
16,713 -16.7% | 0.94 | USD 15,710 | |
| 2023-08-11 | 2023-08-01 | S Sale |
Deputy GC Officer |
3,901
-11.2%
0.94USD 3,667 |
3,901 -11.2% | 0.94 | USD 3,667 | |
| 2023-08-11 | 2023-08-01 | S Sale |
Chief Medical Officer Officer |
7,042
-11.1%
0.94USD 6,619 |
7,042 -11.1% | 0.94 | USD 6,619 | |
| 2023-08-11 | 2023-08-01 | S Sale |
Chief Financial Officer Officer |
9,434
-8.5%
0.94USD 8,868 |
9,434 -8.5% | 0.94 | USD 8,868 | |
| 2022-08-05 | 2022-08-03 | S Sale |
Chief Scientific Officer Officer |
4,463
-4.9%
1.72USD 7,676 |
4,463 -4.9% | 1.72 | USD 7,676 | |
| 2022-08-05 | 2022-08-03 | S Sale |
Chief Financial Officer Officer |
5,980
-5.1%
1.72USD 10,286 |
5,980 -5.1% | 1.72 | USD 10,286 | |
| 2022-08-05 | 2022-08-03 | S Sale |
Chief Medical Officer Officer |
4,463
-6.5%
1.72USD 7,676 |
4,463 -6.5% | 1.72 | USD 7,676 | |
| 2022-08-05 | 2022-08-03 | S Sale |
Chief Executive Officer Officer |
10,594
-9.6%
1.72USD 18,222 |
10,594 -9.6% | 1.72 | USD 18,222 | |
| 2022-08-05 | 2022-08-03 | S Sale |
Chief Business Officer Officer |
5,676
-14.9%
1.72USD 9,763 |
5,676 -14.9% | 1.72 | USD 9,763 | |
| 2022-01-14 | 2021-07-21 | S Sale |
Chief Medical Officer Officer |
14,809
-32.9%
6.10USD 90,335 |
14,809 -32.9% | 6.10 | USD 90,335 | |
| 2022-01-14 | 2021-07-21 | S Sale |
Chief Scientific Officer Officer |
26,325
-32.9%
6.10USD 160,583 |
26,325 -32.9% | 6.10 | USD 160,583 | |
| 2022-01-14 | 2021-07-21 | S Sale |
Chief Executive Officer Officer |
33,500
-38.1%
6.10USD 204,350 |
33,500 -38.1% | 6.10 | USD 204,350 | |
| 2022-01-14 | 2021-07-21 | S Sale | Non-Executive Director |
127,778
-49.7%
6.10USD 779,446 |
127,778 -49.7% | 6.10 | USD 779,446 | |
| 2022-01-14 | 2021-07-21 | S Sale |
Chief Financial Officer Officer |
19,854
-20.0%
6.10USD 121,109 |
19,854 -20.0% | 6.10 | USD 121,109 | |
| 2022-01-14 | 2021-07-21 | S Sale |
Chief Legal Officer Officer |
26,325
-32.9%
6.10USD 160,583 |
26,325 -32.9% | 6.10 | USD 160,583 | |
| 2021-06-11 | 2021-06-11 | S Sale | Non-Executive Director |
15,273
-5.6%
7.61USD 116,226 |
15,273 -5.6% | 7.61 | USD 116,226 | |
| 2021-06-11 | 2021-06-10 | S Sale | Non-Executive Director |
234,727
-47.3%
7.66USD 1,798,619 |
234,727 -47.3% | 7.66 | USD 1,798,619 | |
| 2021-02-18 | 2021-02-16 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-1.1%
11.35USD 11,350 |
1,000 -1.1% | 11.35 | USD 11,350 | |
| 2021-02-09 | 2021-02-08 | PS Planned sale |
Chief Executive Officer Executive Director |
2,500
-0.9%
12.50USD 31,250 |
2,500 -0.9% | 12.50 | USD 31,250 | |
| 2021-02-09 | 2021-02-08 | PS Planned sale |
See Remarks Officer |
1,500
-1.5%
12.45USD 18,675 |
1,500 -1.5% | 12.45 | USD 18,675 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
Chief Executive Officer Executive Director |
2,500
-0.9%
10.69USD 26,718 |
2,500 -0.9% | 10.69 | USD 26,718 | |
| 2021-02-03 | 2021-02-01 | PS Planned sale |
See Remarks Officer |
1,500
-1.5%
11.19USD 16,785 |
1,500 -1.5% | 11.19 | USD 16,785 | |
| 2021-01-21 | 2021-01-19 | PS Planned sale |
Chief Executive Officer Executive Director |
5,000
-1.9%
13.00USD 65,000 |
5,000 -1.9% | 13.00 | USD 65,000 | |
| 2021-01-15 | 2021-01-15 | PS Planned sale |
Chief Medical Officer Officer |
2,000
-2.2%
12.25USD 24,500 |
2,000 -2.2% | 12.25 | USD 24,500 | |
| 2021-01-15 | 2021-01-14 | PS Planned sale |
Chief Medical Officer Officer |
7,000
-7.1%
11.95USD 83,650 |
7,000 -7.1% | 11.95 | USD 83,650 | |
| 2020-12-21 | 2020-12-17 | S Sale | Non-Executive Director |
1,700,000
-36.6%
18.10USD 30,770,000 |
1,700,000 -36.6% | 18.10 | USD 30,770,000 | |
| 2020-12-21 | 2020-12-17 | S Sale | Large shareholder |
1,700,000
-36.6%
18.10USD 30,770,000 |
1,700,000 -36.6% | 18.10 | USD 30,770,000 | |
| 2020-12-17 | 2020-12-15 | PS Planned sale |
Chief Medical Officer Officer |
1,000
-1.0%
10.48USD 10,480 |
1,000 -1.0% | 10.48 | USD 10,480 | |
| 2020-12-15 | 2020-12-11 | PS Planned sale |
Chief Medical Officer Officer |
1,405
-1.4%
10.05USD 14,120 |
1,405 -1.4% | 10.05 | USD 14,120 | |
| 2020-11-13 | 2020-11-11 | PS Planned sale |
Chief Medical Officer Officer |
595
-0.6%
10.05USD 5,980 |
595 -0.6% | 10.05 | USD 5,980 | |
| 2020-10-16 | 2020-10-14 | PS Planned sale |
Chief Medical Officer Officer |
4,000
-3.8%
10.05USD 40,200 |
4,000 -3.8% | 10.05 | USD 40,200 | |
| 2020-09-03 | 2020-09-01 | S Sale | Large shareholder |
332,780
-6.6%
7.14USD 2,376,681 |
332,780 -6.6% | 7.14 | USD 2,376,681 | |
| 2020-05-22 | 2020-05-20 | S Sale |
New Enterprise Associates 14, L.P. Large shareholder |
420,000
-12.7%
3.66USD 1,535,562 |
420,000 -12.7% | 3.66 | USD 1,535,562 | |
| 2020-02-07 | 2020-02-05 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+1.9%
3.23USD 16,150 |
5,000 +1.9% | 3.23 | USD 16,150 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Atlas Venture Fund IX, L.P. Large shareholder |
100,000
+2.2%
15.00USD 1,500,000 |
100,000 +2.2% | 15.00 | USD 1,500,000 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Viswanathan Ravi Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Sonsini Peter W. Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Florence Anthony A. Jr. Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
GRAYZEL DAVID S. Non-Executive Director |
100,000
+2.2%
15.00USD 1,500,000 |
100,000 +2.2% | 15.00 | USD 1,500,000 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
New Enterprise Associates 14, L.P. Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
LV Management Group, LLC Large shareholder |
266,000
+8.4%
15.00USD 3,990,000 |
266,000 +8.4% | 15.00 | USD 3,990,000 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Shanafelt Armen Non-Executive Director Large shareholder |
266,000
+8.4%
15.00USD 3,990,000 |
266,000 +8.4% | 15.00 | USD 3,990,000 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
BARRIS PETER J Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
BARRETT M JAMES Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
Novartis Institutes for BioMedical Research, Inc. Large shareholder |
766,666
+24.1%
15.00USD 11,499,990 |
766,666 +24.1% | 15.00 | USD 11,499,990 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
KERINS PATRICK J Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
SANDELL SCOTT D Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
MOTT DAVID M Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 | |
| 2018-04-23 | 2018-04-23 | B Purchase |
BASKETT FOREST Large shareholder |
133,333
+4.2%
15.00USD 1,999,995 |
133,333 +4.2% | 15.00 | USD 1,999,995 |